LoadingLoadingLoadingThe quick read
Latest quote·Oct 15
Net selling: insiders sold $548.5M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNet selling: insiders sold $548.5M and bought $0 of ABNB stock on the open market in the 90 days to Oct 15, 2026, according to SEC Form 4 filings. $548.5M of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Gebbia, Joseph (Director), who sold $315.9M. The latest filing was on Oct 14, 2026.
None. No member of Congress disclosed a ABNB trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
This summary uses filings available on Oct 15, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position and insiders have been net selling.
Buys/Adds (1)
Qube Research
$120.1M
bought
Sells/Trims (2)
D.E. Shaw
$224.0M
trimmed
SRS Investment Mgmt
$134.6M
trimmed
Sells (1)
No tracked top-trader positions in ABNB right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Aug 6, 2026
Financial period
Q2 2026
Earnings per share
$1.25 expected
Revenue
$3.58B expected
Q3 2026 guidance
$4.69B to $4.77B
$4.61B expected+2.7%at the midpoint
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | $1.27 / $1.25Company release | +1.69% beat | $3.60B / $3.58B | +0.68% beat |
| Mar 31, 2026 | May 7, 2026 | $0.26 / $0.31Yahoo Finance | -14.85% miss | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 12, 2026 | $0.56 / $0.65Yahoo Finance | -13.76% miss | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 6, 2025 | $2.21 / $2.31Yahoo Finance | -4.42% miss | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 6, 2025 | $1.03 / $0.94Alpha Vantage | +9.57% beat | Unavailable | Unavailable |
| Mar 31, 2025 | May 1, 2025 | $0.24 / $0.24Alpha Vantage | +0.00% in line | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 13, 2025 | $0.73 / $0.58Alpha Vantage | +25.86% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 7, 2024 | $2.13 / $2.13Alpha Vantage | +0.00% in line | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Estimates as of Oct 15, 2026
EPS expected
$2.61 to $3.34
Revenue expected
36 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $4.09B | $2.80B | $2.68B | $3.61B |
| Cost of what it sold | $549.0M | $814.0M | $907.0M | $633.0M |
| Gross profit | $3.55B | $1.99B | $1.77B | $2.98B |
| What it spent | ||||
| Research and development | $587.0M | $589.0M | $638.0M | $672.0M |
| Sales and admin | $330.0M | $411.0M | $296.0M | $309.0M |
| Other operating costs | $1.00B | $693.0M | $753.0M | $1.24B |
| Total operating expenses | $1.92B | $1.69B | $1.69B | $2.22B |
| What was left | ||||
| Operating profit | $1.63B | $294.0M | $84.0M | $759.0M |
| Interest on debt | — | — | — | $37.0M |
| Profit before tax | $1.79B | $393.0M | $281.0M | $897.0M |
| Tax | $418.0M | $52.0M | $121.0M | $81.0M |
| Net profit | $1.37B | $341.0M | $160.0M | $816.0M |
| EBITDA | $1.81B | $317.0M | $106.0M | $776.0M |
This stock's price action is mixed, and looks overbought after a fast run-up.
Trend
Mixed
45 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
HUTCHMED (China) (AIM:HCM) FDA Filing Puts Its Undervalued Narrative Back In Focus
Leans bullishOct 13Raymond James Financial (RJF) Could Be 15% Undervalued Following Technology Banking Hire
BearishOct 12Applied Digital (APLD) Could Be 64% Undervalued Following Its Latest Quarterly Results
NeutralOct 12Lucid Group (LCID) Sets Up France Launch With More Than 16 Locations
NeutralOct 12Radware (RDWR) Launches Agent Trust Management, Is The Valuation Premium Already Priced In?
NeutralOct 12Amazon, Tesla, Airbnb among consumer discretionary stocks with A+ profitability grades
BullishOct 12Axalta Coating Systems (AXTA), What Is Drawing Fresh Attention Now?
Leans bullishOct 12Cal-Maine Foods (CALM) Turns To Loss After Q1 Results As Valuation Debate Builds
Leans bullishOct 12